Registration is Open!

IMPORTANT DATES

• 31 May 2022: Early registration deadline
• 15 June 2022: Travel Grant application deadline
• 17 September 2022: Regular registration deadline
• 18 September 2022: Pre-congress symposium
• 18–21 September 2022: Congress days

New preliminary programme is available now!

Updated preliminary programme is available now! https://www.iatdmct2022.org/programme/

TRAVEL GRANTS
If you are a scientist with 10 years or less experience in the field of TDM or clinical toxicology, or a scientist from a developing country (see IATDMCT membership application information) you may consider to apply. More information on eligibility requirements and the application process can be found at www.iatdmct.org/awards/international-travel-grant.html.

According to the policy, IATDMCT will offer a number of travel grants—for up to US$1,000 each—to attend the IATDMCT meeting in Prague, Czech Republic.
• Applications for Travel Grants close 15 June 2022.

Deadline April 30, 2022

The Call for Nominations for the 2022 IATDMCT awards is still open!

This year you are invited to nominate individuals for the following IATDMCT Awards:

• C.E. Pippenger Award, Presented for Outstanding Contributions to Therapeutic Drug Monitoring
• Victor Armstrong Young Investigator Award, Presented to a Young Investigator for Exceptional Scientific Achievements Early in His/Her Career

The Call for Nominations is open until April 30, 2022. The award presentations will take place at the Opening Ceremony of the 20th IATDMCT Congress in Prague, Czech Republic.

Nominations from members must be accompanied by curriculum vitae including a list of publications and a letter of support from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support from members of the Association or other respected scientists are welcomed as supporting information for the Selection Committee.

Submit your nominations to:
Yusuke Tanigawara, Chair of the Awards Committee

Click here to email your nomination

Dear colleagues,

Uwe Christiansen (Editor in Chief) and Maria Shipkova (Review Editor) of Therapeutic Drug Monitoring plan a special issue of the journal to honour the pioneer work of Professor Charles Pippenger, the founder of the Journal.

The theme of said Issue will be “Innovations in Therapeutic Drug Monitoring”. Appreciated are original manuscripts, opinion papers as well as critical reviews on emerging technologies and approaches in the field of Therapeutic Drug Monitoring.

To allow the proper allocation of your submission, please indicate that you will like the work to be considered for the Special Issue “Innovations in Therapeutic Drug Monitoring” in your cover letter of the submission.

Deadline: June 30

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2022 Member-Get-A Member Campaign now is up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let’s build a strong partnership together!

New Campaign Deadline: August 31, 2022.

As usual the top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2022 in Prague.

Click here for complete participation details!

Find the latest news and follow our IATDMCT institutional page on LinkedIn!

Click here to access the page!

This month we hear from Florian Lemaitre, who recently contributed this piece to our newsletter Compass on behalf of the Immunosuppressive Drug Committee. Florian uses three cases to illustrate unusual drug-drug interactions affecting people on regular immunosuppressant drugs. Can you guess what happened in each case?

Read more

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online on February 21 – April 10, 2022:

Original Articles:

• High Tacrolimus Intra-Patient Variability and Subtherapeutic Immunosuppression Are Associated with Adverse Kidney Transplant Outcomes.
  Mendoza Rojas, A.; Hesselink, D.A.; van Besouw, N.M.; Dieterich, M.; de Kuiper, P.; Baan, C.C.; van Gelder, T.
• Towards precision dosing of clozapine in schizophrenia: external evaluation of population pharmacokinetic models and Bayesian forecasting.
  Lereclus, Aurélie; Korchia, Théo; Riff, Camille; Dayan, Frédéric; Blin, Oliver; Benito, Sylvain; Guilhaumou, Romain.
• An Audit To Evaluate Vancomycin Therapeutic Drug Monitoring In A Neonatal Intensive Care Unit.
  Alrahahleh, Dua'a; Xu, Sophia; Zhu, Zhaowen; Toufaili, Hassan; Luig, Melissa; Kim, Hannah Yejin; Alffenaar, Jan-Willem.
• High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood using Ultra-High-Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry.
  Miyagi, Chika; Tanaka, Ryota; Hirata, Kenshiro; Watanabe, Takuma; Tatsuta, Ryosuke; Miyamura, Shigeyuki; Itoh, Hiroki.
• Development and Validation of a Dried Blood Spot Assay Using UHPLC-MS/MS to Identify and Quantify 12 Antihypertensive Drugs and 4 Active Metabolites: Clinical Needs and Analytical Limitations.
  Peeters, Laura E.J.; Bahmany, Soma; Dekker, Tim; Aliawi, Aya; van Domburg, B.; Versmissen, Jorie; Koch, Birgit C.P.
• Evaluation of a Highly Efficient Multi-drug Biochip Array Technology for a Simultaneous and High-throughput Urine Drug Screening in Clinical and Toxicological Settings.
  Castaneto, Marisol S.; Huang, Chihyon; Capps, Duriza; Ke, Pucheng; VanZile, Michael; Calero, Eva.
• The association between the intracellular tacrolimus concentration in cd3+ t lymphocytes and cd14+ monocytes and acute kidney transplant rejection.
  Udomkarnjananun, Suwasin; Francke, Marith I.; Dieterich, Marjolein; van de Velde, Daan; Verhoeven, Jeroen G.H.P.; Boer, Karin; Clahsen-Van Groningen, Marian C.; De Winter, Brenda C.M.; Baan, Carla C.; Hesselink, Dennis A.
• Dosing for Personalized Prophylaxis in Hemophilia A highly varies on the underlying Population Pharmacokinetic Models.
  Uster, David W.; Chowdary, Pratima; Riddell, Anne; Garcia, Cecilia; Aradom, Elsa; Musarara, Molly; Wicha, Sebastian G.
• Model-Based Tacrolimus Follow-Up Dosing in Adult Renal Transplant Recipients: A Simulation Trial.
  Francke, Marith I; Hesselink, Dennis A; Andrews, Louise M; Van Gelder, Teun; Keizer, Ron J; De Winter, Brenda C M.
• Real-world comparison of isavuconazole and voriconazole in terms of the need for dosage adjustments guided by clinical pharmacological advice during primary prophylaxis of invasive fungal infections in pediatric patients with hemato-oncological malignancies.
  Gatti, Milo; Campoli, Caterina; Belotti, Tamara; Cojutti, Pier Giorgio; Masetti, Riccardo; Pession, Andrea; Viale, Pierluigi; Pea, Federico.

The Communication Committee would like to inform the membership that advertisements for professional positions (Ph.D. and Post-Doc job opportunities) in the field of TDM/CT, will be published in the E-news instead of on the IATDMCT website. Please e-mail the office with the advertisement for the position and it will be published in an upcoming monthly E-news. (IATDMCT office email: info@iatdmct.org)

Below please find informative links about the current situation, which specifically addresses the rapid identification of COVID-19 cases as well as adverse reactions due to interaction of drugs:

• The IATDMCT website provides a list of COVID-19 resources
• Drugs used to treat COVID-19 that may interact with other medication
• ASHP's Covid-19 Resource Center

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

The annual Charles Lieber Satellite Symposium will take place June 23.

RSA-2022 Meeting, June 24-29, Orlando, Florida, USA

The Research Society on Alcoholism© serves as a meeting ground for scientists in the broad areas of alcoholism and alcohol-related problems. The Society promotes research and the acquisition and dissemination of scientific knowledge.

IATDMCT and The French Society for Pharmacology will organize, in June 2022, an onsite symposium and virtual meeting at Rennes University Hospital in France. This will be an international symposium.

The registration is free!

To register: download this pdf and link with the QR code, or click here for the online registration form.

For more information please e-mail: pharmaco.rennes@gmail.com.

The Annual Scientific Meeting of the Canadian Society of Clinical Chemists (CSCC) will take place June 5-8 in Niagara Falls, Canada.

Earlybird registration deadline April 30, 2022. Click here to learn more!

NACCT is now accepting abstracts for the 2022 Annual Meeting until 25 April! " Advancement of research, education, prevention and treatment of diseases caused by chemicals, drugs and toxins", Sept 14–18, 2022 in San Francisco, CA. Click here for details!

Registration and Abstract submission are now open for the XVI International Congress of Toxicology in Maastricht, The Netherlands, September 18-21, 2022. Click here for details!

This congress is jointly organized with the International Union of Toxicology (IUTOX) and the European Society of Toxicology (EUROTOX), and unites the best of toxicological scientists worldwide in the historical city of Maastricht.

ISOP is now accepting abstracts for the 2022 Annual Meeting until 13 May! "A New Era of Pharmacovigilance: Challenges and Opportunities", Sept 20 - 23, 2022 in Verona, Italy. Click here for details!

ACCP is now accepting abstracts for the 2022 ACCP Annual Meeting! "Transforming Global Health through Clinical Pharmacology", Sept 25 - 27, 2022 in Bethesda, MD.

Visit today for more information!

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.